NCT02535611View on ClinicalTrials.gov

Evaluation of Memantine Versus Placebo on Ischemic Stroke Outcome

PHASE3CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

September 30, 2017

Conditions
Ischemic StrokeExcitotoxicityMemantine
Interventions
DRUG

Placebo

Beside the usual treatment of ischemic stroke, this group will receive placebo for 4 weeks.

DRUG

Memantine

Beside the usual treatment for ischemic stroke this group will be treated by memantine.

All Listed Sponsors
lead

Mazandaran University of Medical Sciences

OTHER

NCT02535611 - Evaluation of Memantine Versus Placebo on Ischemic Stroke Outcome | Biotech Hunter | Biotech Hunter